John Terrig Thomas

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces
    J Terrig Thomas
    Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland 20892, USA
    J Biol Chem 281:26725-33. 2006
  2. ncbi Vg1 has specific processing requirements that restrict its action to body axis patterning centers
    John Terrig Thomas
    Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, U S Food and Drug Administration, Bethesda, MD 20892, USA
    Dev Biol 310:129-39. 2007
  3. ncbi Xenopus SMOC-1 Inhibits bone morphogenetic protein signaling downstream of receptor binding and is essential for postgastrulation development in Xenopus
    J Terrig Thomas
    Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland 20892, USA
    J Biol Chem 284:18994-9005. 2009
  4. ncbi A homolog of Subtilisin-like Proprotein Convertase 7 is essential to anterior neural development in Xenopus
    Sema Senturker
    Division of Cellular and Gene Therapies, Center for Biologics, Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland, United States of America
    PLoS ONE 7:e39380. 2012

Collaborators

  • Sema Senturker
  • Jennifer Mateshaytis
  • Malcolm Moos

Detail Information

Publications4

  1. ncbi CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces
    J Terrig Thomas
    Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland 20892, USA
    J Biol Chem 281:26725-33. 2006
    ..Taken together, these observations provide a plausible mechanism for local action of CDMP1/GDF5 consistent with requirements imposed by current models of pattern formation in the developing limb...
  2. ncbi Vg1 has specific processing requirements that restrict its action to body axis patterning centers
    John Terrig Thomas
    Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, U S Food and Drug Administration, Bethesda, MD 20892, USA
    Dev Biol 310:129-39. 2007
    ..Taken together, these observations provide a plausible mechanism for local action of Vg1 consistent with requirements imposed by current models of pattern formation in the developing body axis...
  3. ncbi Xenopus SMOC-1 Inhibits bone morphogenetic protein signaling downstream of receptor binding and is essential for postgastrulation development in Xenopus
    J Terrig Thomas
    Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland 20892, USA
    J Biol Chem 284:18994-9005. 2009
    ..These findings provide a direct link between the extracellular matrix-associated protein SMOC and a signaling pathway of general importance in anatomic patterning and cell or tissue fate specification...
  4. ncbi A homolog of Subtilisin-like Proprotein Convertase 7 is essential to anterior neural development in Xenopus
    Sema Senturker
    Division of Cellular and Gene Therapies, Center for Biologics, Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland, United States of America
    PLoS ONE 7:e39380. 2012
    ..Other SPCs are known to be required during embryonic development but corresponding data regarding SPC7 have not been reported previously...